Table 1. Recruiting prospective clinical trials of liver transplantation for cholangiocarcinoma.

Type	Estimated participants	Stage	Combined therapy	Institution/country	Study start date	Estimated study completion date	Phase	ClinicalTrials.gov ID
iCCA	30	Very early	NA	University Health Network, Canada	April 2018	January 2029	Phase II	NCT02878473
iCCA	15	Unresectable	nCRT	Oslo University Hospital, Norway	June 2020	May 2035	NA	NCT04556214
pCCA	15	Unresectable	nCRT	Oslo University Hospital, Norway	September 2021	May 2045	NA	NCT04993131
pCCA	34	Unresectable	nCRT	Hospital Vall d'Hebron, Spain	April 2020	June 2025	NA	NCT04378023
CCA	100	Unresectable	nCRT	Washington University School of Medicine, USA	August 2005	December 2022	NA	NCT00301379

iCCA, intrahepatic cholangiocarcinoma; pCCA, perihilar cholangiocarcinoma; NA, not applicable; nCRT, neoadjuvant chemoradiotherapy.